Christoph Petry
Chief Executive Officer bij m2p-labs GmbH
Profiel
Christoph Petry founded Myriad International GmbH in 2010, where he worked as Chief Executive Officer & Managing Director.
Dr. Petry also currently works at m2p-labs GmbH, as Co-Managing Director & Chief Technology Officer from 2017.
Dr. Petry also formerly worked at Prostatype Genomics AB, as Director, Bayer AG, as Head-Research & Development, Siemens AG, as Head-Molecular Research, and Bayer Diagnostics Corp., as Principal.
Dr. Petry received his graduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Actieve functies van Christoph Petry
| Bedrijven | Functie | Begin |
|---|---|---|
m2p-labs GmbH
 m2p-labs GmbH BiotechnologyHealth Technology m2p-labs GmbH manufactures and supplies micro bioreactors. The firm focuses on micro reaction and automated solutions for screening and bioprocess development. Its commercialized products are the BioLector and the FlowerPlate which provide an intelligent micro fermentation platform. The firm's technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments. The company was founded by Ingo Klammer, Carsten Müller, Mirko C. Hofmann and Frank Kensy on November 22, 2005 and is headquartered in Baesweiler, Germany. | Chief Executive Officer | 01-10-2017 |
Eerdere bekende functies van Christoph Petry
| Bedrijven | Functie | Einde |
|---|---|---|
| BAYER AG | Chief Tech/Sci/R&D Officer | - |
| PROSTATYPE GENOMICS AB | Director/Board Member | - |
Myriad International GmbH
 Myriad International GmbH Medical/Nursing ServicesHealth Services Myriad International GmbH provides diagnostics services in oncology. Its products include EndoPredict, Report Generator and ChemoPredict. The firm conducts research with clinical and scientific partners. The company was founded by Ralf Kronenwett, Christoph Petry and Kerstin Bohmann in July 2010 and is headquartered in Cologne, Germany. | Chief Executive Officer | - |
| SIEMENS AG | Chief Tech/Sci/R&D Officer | 02-09-2011 |
| Bayer Diagnostics Corp. | Corporate Officer/Principal | - |
Opleiding van Christoph Petry
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BAYER AG | Health Technology |
| SIEMENS AG | Producer Manufacturing |
| PROSTATYPE GENOMICS AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Bayer Diagnostics Corp. | Health Technology |
m2p-labs GmbH
m2p-labs GmbH BiotechnologyHealth Technology m2p-labs GmbH manufactures and supplies micro bioreactors. The firm focuses on micro reaction and automated solutions for screening and bioprocess development. Its commercialized products are the BioLector and the FlowerPlate which provide an intelligent micro fermentation platform. The firm's technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments. The company was founded by Ingo Klammer, Carsten Müller, Mirko C. Hofmann and Frank Kensy on November 22, 2005 and is headquartered in Baesweiler, Germany. | Health Technology |
Myriad International GmbH
Myriad International GmbH Medical/Nursing ServicesHealth Services Myriad International GmbH provides diagnostics services in oncology. Its products include EndoPredict, Report Generator and ChemoPredict. The firm conducts research with clinical and scientific partners. The company was founded by Ralf Kronenwett, Christoph Petry and Kerstin Bohmann in July 2010 and is headquartered in Cologne, Germany. | Health Services |
